Ningaloo Biosystems

Ningaloo Biosystems is a German biotechnology company specializing in light-controlled bioprocessing solutions to optimize the production of complex biologics. The company leverages optogenetics to provide precise, non-invasive control over cellular processes in real-time, aiming to improve yield and quality for products such as monoclonal antibodies and cell therapies. Their platform integrates smart analytics with automated hardware to streamline process development and manufacturing workflows. By replacing chemical inducers with light, Ningaloo Biosystems offers a cleaner and more scalable approach to biopharmaceutical production. The technology is designed to reduce the time and cost associated with developing high-performing cell lines and production processes.